Face the same risk landscape as other IPOs and company buyers. Transactions are complex, time-critical and highly specialized. SPAC leaders need partners who understand their goals and challenges and bring robust knowledge to the table. Aon is that partner.
In addition to our D&O experience, Aon provides myriad solutions to mitigate client risk and exposure, protect M&A activity and uncover opportunities, including:
The Biotechnology Innovation Organization (“BIO”) and Aon have collaborated to provide comprehensive cyber and management liability insurance programs to BIO organizations. | |
Aon helps clients protect and create enterprise value for their largest asset holdings in today’s business world – their intellectual property. | |
Industry specialists such as Radford (life science & technology) and McLagan (financial services) provide consulting services such as executive and director compensation, employee rewards, career strategies, equity strategy and plan design, and sales compensation and effectiveness. | |
A full suite of products (including reps & warranties, tax and litigation buyout) to explore strategic alternatives alongside the public offering efforts, or to help mitigate obstacles to a successful offering. |
Before a private company signs a letter of intent with a SPAC investor, business leaders should ensure their executive compensation plans are in good standing and commit to a deeper governance audit once the deal is signed.
Companies are considering whether they should consider a SPAC business combination as a possible alternative to a traditional IPO. Access a replay of a September 2020 webinar hosted by Aon leaders joined by a panel of legal and financial experts.
Top considerations for SPAC organizers with respect to management liability exposures and solutions to address exposures.